First Circuit asks Sanofi to prove patent claims were in good faith

Direct purchasers stated a claim for monopolisation against Sanofi-Aventis, the US Court of Appeals for the First Circuit has held, and the drugmaker must prove its defence was in good faith.

Get unlimited access to all Global Competition Review content